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Posokhova et al. show that GPR124
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G protein-coupled receptor 124 (GPR124) is an
orphan receptor in the adhesion family of GPCRs,
and previous global or endothelial-specific dis-
ruption of Gpr124 in mice led to defective CNS an-
giogenesis and blood-brain barriergenesis. Similar
developmental defects were observed following
dual deletion of Wnt7a/Wnt7b or deletion of b-cate-
nin in endothelial cells, suggesting a possible rela-
tionship between GPR124 and canonical WNT
signaling. Here, we show using in vitro reporter as-
says, mutation analysis, and genetic interaction
studies in vivo that GPR124 functions as a WNT7A/
WNT7B-specific costimulator of b-catenin signaling
in brain endothelium. WNT7-stimulated b-catenin
signaling was dependent upon GPR124’s intracel-
lular PDZ binding motif and a set of leucine-rich re-
peats in its extracellular domain. This study reveals
a vital role for GPR124 in potentiation of WNT7-
induced canonicalb-catenin signalingwith important
implications for understanding and manipulating
CNS-specific angiogenesis and blood-brain barrier-
genesis.
INTRODUCTION
In vertebrates, the endothelium lining the vasculature of each or-
gan is highly specialized in order to meet the particular physical
and metabolic needs of each tissue. CNS endothelium is no
exception, displaying a highly diverse and unique set of cell-sur-
face proteins including a large number of CNS-specific trans-
porters that contribute to blood-brain barrier (BBB) function
(Seaman et al., 2007). Mechanisms regulating developmental
CNS angiogenesis are distinct from non-CNS angiogenesis
and are tightly coupled to BBB properties that develop concom-
itantly as vessels invade the neural tube (Daneman et al., 2009;
Stenman et al., 2008). Understanding mechanisms that regulateCCNS-specific angiogenesis and barriergenesis has important
ramifications for developing themost selective therapies to com-
bat brain tumors and other cerebrovascular and neurodegener-
ative disorders.
Angiogenesis in the CNS begins when endothelial cells from
the perineural vascular plexus (PNVP) invade the neural paren-
chyma. WNT7 plays a critical role in this process because
Wnt7a/Wnt7b double-knockout mice display defective angio-
genesis in the forebrain and ventral spinal cord and fail to estab-
lish an effective BBB (Daneman et al., 2009; Stenman et al.,
2008). In the afflicted regions, the few vessels that sprout into
the neural tissues form unusual tangles called glomeruloids, so
named because of their superficial resemblance to kidney
glomeruli (Sundberg et al., 2001). Endothelial disruption of b-cat-
enin (Ctnnb1) or simultaneous deletion of the Wnt coreceptors
Lrp5 and Lrp6 in endothelium also results in defects in CNS
vascular morphogenesis and barriergenesis (Daneman et al.,
2009; Stenman et al., 2008; Zhou et al., 2014). Together, these
studies suggest canonical b-catenin signaling plays a major
role in CNS angiogenesis with WNT7A/WNT7B functioning non-
redundantly in specific anatomical locations.
G protein-coupled receptor 124 (GPR124), also known as tu-
mor endothelial marker 5 (TEM5), was originally identified as
a gene whose transcripts were elevated in the endothelium
derived from tumor versus normal tissues (Carson-Walter
et al., 2001; St Croix et al., 2000). GPR124 is an orphan member
of the adhesion family of GPCRs, and its involvement in cell
signaling has not heretofore been shown. Disruption of Gpr124
in mice led to defects in the developing CNS that share striking
similarity toWnt7a/Wnt7b double-knockout mice—that is, blunt-
ed angiogenesis with unusual glomeruloid structures formed
specifically in the forebrain and ventral spinal cord and a lack
of barrier properties in the afflicted regions (Anderson et al.,
2011; Cullen et al., 2011; Kuhnert et al., 2010). Based on the
striking phenotypic similarity between Gpr124/ knockout
mice and Wnt7a//Wnt7b/ double-knockout mice, we set
out to explore a possible connection between GPR124 and
WNT7A/WNT7B and found that GPR124 functions as a coactiva-
tor of WNT7A/WNT7B induced b-catenin signaling in developing
brain endothelium.ell Reports 10, 123–130, January 13, 2015 ª2015 The Authors 123
Figure 1. Gpr124 Is Required for b-Catenin Signaling in Brain Endothelium In Vivo
(A) b-galactosidase (b-gal)-positive nuclei (blue; arrows), indicative of b-catenin signaling, were observed in the isolectin (ISL)-positive vessels (red) that pene-
trated the lateral ventricular wall in the telencephalon (neopallium) of Gpr124+/+; BAT-Gal+ mice (left). Blue nuclei were absent from the glomeruloid vessel
structures (yellow arrowheads) found in the lateral ventricular wall of the telencephalon of Gpr124/; BAT-Gal+ mice (right panel). Scale bars, 50 mm.
(B) Quantification of the number of b-gal-positive nuclei per vessel structure in Gpr124+/+; BAT-Gal+ (WT) or Gpr124/; BAT-Gal+ (KO) neopallium. *p < 0.0001
(C) b-gal-positive nuclei (blue) were observed in isolectin (ISL)-positive vessels (red) throughout the spinal cord of Gpr124+/+; BAT-Gal+ mice (left). Blue nuclei
were observed in the dorsal (D) side of Gpr124/; BAT-Gal+ spinal cord but were absent from the glomeruloid vessel structures (yellow arrowheads) found in the
ventral (V) side (inset, right). Scale bars, 100 mm.
(D) Quantification of the number of b-gal positive nuclei per vessel structure in the ventral or dorsal region of Gpr124+/+; BAT-Gal+ (WT) or Gpr124/; BAT-Gal+
(KO) spinal cord. *p < 0.0001. The rare b-gal+ nuclei found in Gpr124/ forebrain (B) or in the ventral region of the spinal cord (D) were located in vessel stalks
interconnecting the glomeruloids with the underlying PNVP. Data in (B) and (D) are mean ± SEM.RESULTS AND DISCUSSION
GPR124 Is Required for b-Catenin Signaling In Vivo
To determine if the angiogenesis defects in Gpr124/ mice are
caused by abnormal b-catenin signaling, we began by moni-
toring b-catenin activity in the CNS vasculature of Gpr124/
embryos that contained a b-galactosidase transgene driven by
the b-catenin responsive TCF/LEF promoter, i.e., the BAT-Gal
reporter. In Gpr124+/+; BAT-Gal+ mice, b-galactosidase nuclear
staining was prominent in isolectin-positive vessels throughout
the brain and spinal cord, consistent with earlier reports (Liebner
et al., 2008). However, b-galactosidase staining was undetect-
able in the glomeruloid vessels of Gpr124/; BAT-Gal+ fore-
brains, indicating a loss of b-catenin signaling in these regions
(Figures 1A and 1B). In the spinal cord of Gpr124/ mice,
b-galactosidase staining was readily observed in the normal
vessels of the dorsal region but was undetectable in the glomer-124 Cell Reports 10, 123–130, January 13, 2015 ª2015 The Authorsuloids found in the ventral side, although occasional b-galacto-
sidase-positive nuclei were found in the vessel stalks that
connected the glomeruloids to the underlying PNVP (Figures
1C and 1D). These results strongly suggest that GPR124 is
required for b-catenin signaling in particular anatomical locations
of the CNS.
GPR124 Is a Coactivator of WNT7-Specific b-Catenin
Signaling
To determine if GPR124 could also regulate b-catenin signaling
in vitro, we began by introducing a TCF/LEF-luciferase reporter
into human embryonic kidney 293 (HEK293) cells, a cell system
widely used to monitor WNT signaling. These studies revealed
up to a 12-fold increase in WNT7-induced luciferase expression
upon coexpression of GPR124 (Figure S1). Although HEK293 re-
porter cells are widely used to monitor b-catenin signaling, we
detected a low level of endogenous GPR124 in this cell line,
Figure 2. GPR124 Is a Ligand-Specific Co-
activator of Canonical b-Catenin Signaling
(A) Transfection of BKO reporter cells with
increasing concentrations of FLAG-GPR124
caused a dose-dependent increase in luciferase
activity in response to WNT7A.
(B) WNT7A and WNT7B with and without a myc
tag stimulated luciferase activity in BKO cells in
combination with GPR124. *p < 0.001.
(C) Mouse and human GPR124 both enhanced
WNT7A induced luciferase activity in BKO cells.
(D) N-terminal FLAG or C-terminal myc tags did
not alter GPR124’s ability to coactivate WNT7A
signaling. GPR125 did not enhance WNT7A
signaling. p < 0.01 versus pcDNA plus WNT7A.
(E) qPCR analysis revealed higher levels of Axin2
and Apcdd1 mRNA expression in doxycycline-
induced BKO-124i cells.
(F) GPR124 selectively enhanced WNT7A and
WNT7B induced luciferase activity in BKO-124i
cells. *p < 0.004
(G) GPR124 enhanced the activity of ectopically
expressed WNT7 in BKO-124i cells. HEK293 cells
were transfected with pcDNA3.1 (pcDNA), WNT2,
WNT7A, or WNT7B, then 24 hr later mixed with
BKO-124i reporter cells and cocultured for 24 hr in
the presence or absence of doxycycline (Dox)
prior to luciferase analysis. *p = 0.04, **p = 0.005.
Data are mean ± SEM. See also Figures S2
and S3.which could potentially confound interpretation of results (B.S.C.
and S.S., unpublished data). To create a more physiologically
relevant reporter on a Gpr124 null background, we introduced
a TCF/LEF-driven luciferase vector into Gpr124/ immortalized
brain endothelial cells (BECs) derived from the isolectin-positive
cell fraction of forebrain microdissected from embryonic day
13.5 (E13.5) embryos (see Experimental Procedures for details).
The endothelial origin of the BEC Gpr124 knockout (BKO) re-
porter cell line was verified by immunofluorescence staining
and RT-PCR analysis for the endothelial markers vascular endo-
thelial cadherin (cdh5), vascular endothelial growth factor recep-
tor 2 (vegfr2), and laminin (Figure S2). The BKO cells also stained
positive for isolectin B4 (Figure S2D). All ten frizzled Wnt recep-
tors were also detected in BKO cells by RT-PCR analysis (Fig-
ure S2A). BKO cells displayed a 2-fold increase in luciferase
activity in response to WNT7A expression alone, but luciferase
activity increased dose dependently a further 6-fold upon co-
transfection of WNT7A and GPR124 (Figure 2A). Similar results
were obtained using a stable GPR124 inducible reporter cellCell Reports 10, 123–130line, called BKO-124i, which was engi-
neered to express GPR124 upon expo-
sure to doxycycline (Figures S2C and
S3A). WNT7B showed similar activity to
WNT7A stimulating luciferase activity up
to 5-fold in combination with GPR124
(Figure 2B). Mouse GPR124 and human
GPR124 also showed similar costimula-
tory activity, and addition of an N-terminal
FLAG tag or a C-terminal myc tag toGPR124 did not interfere with its ability to potentiate WNT
signaling (Figures 2C and 2D). GPR124 expression alone was
unable to provoke luciferase activity, and GPR125, the closest
homolog of GPR124, was unable to augment WNT7-induced
luciferase activity (Figures 2A, 2B, and 2D).
In order to verify that the luciferase reporter was accurately
measuring b-catenin transcription in BKO cells, we expressed
WNT7A, WNT7B, and GPR124 (Figure S2) and used real-time
quantitative PCR (qPCR) to monitor changes in mRNA levels of
Axin2 and Apcdd1, genes known to be activated by b-catenin
(Jho et al., 2002; Takahashi et al., 2002). As shown in Figure 2E,
the expression of Axin2 and Apcdd1 was stimulated by coex-
pression of GPR124 with WNT7A or WNT7B, demonstrating
that GPR124 enhances theWNT7A/WNT7B-induced expression
of b-catenin target genes.
Previously described coactivators of canonical WNT signaling
such as LRP5 and LRP6, potentiate the activity of many WNTs
(Tamai et al., 2004). To determine whether GPR124 is also a
broad-spectrum coactivator or if it preferentially activates, January 13, 2015 ª2015 The Authors 125
Figure 3. Mutation Analysis Identifies Amino Acids of WNT7A and GPR124 Important for b-Catenin Signaling
(A) Western blotting reveals that each of the mutant WNT7A proteins was expressed in BKO cells at a level similar to the wild-type (WT) WNT7 protein. The
schematic on top depicts the relative location of each mutation as well as the C-terminal myc tag.
(B) Luciferase activity in BKO cells increased in response to wild-type (WT) WNT7A upon coexpression of GPR124 but was attenuated by each of the WNT7A
mutations. *p < 0.002
(legend continued on next page)
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WNT7A andWNT7B, we measured reporter activity in BKO-124i
cells in response to all 19 WNTs. RT-PCR analysis verified that
each of the 19WNTswas expressed following transient transfec-
tion of reporter cells (Figure S3B). Strikingly, WNT7A andWNT7B
were the only WNTs that displayed significantly elevated activity
in combination with GPR124, although some WNTs, such as
WNT1, WNT2, WNT3, and WNT3a, were able to stimulate lucif-
erase activity independent of GPR124 (Figures 2F and S3C).
These results indicate that GPR124 is a ligand-specific coactiva-
tor of canonical b-catenin signaling in brain endothelium.
GPR124 could potentially enhance WNT7 activity by aiding in
the proper folding, biosynthesis, or secretion of WNT7. Alterna-
tively, GPR124may act at the cell surface to augment the activity
of functionally mature WNT7. To distinguish between these pos-
sibilities, we transfected HEK293 cells with empty pcDNA3 vec-
tor (a negative control), WNT2 (a positive control), WNT7A, or
WNT7B, mixed each of the transfectants with BKO-124i reporter
cells, cocultured them for 24 hr in the presence or absence of
doxycycline, and then measured luciferase activity. Ectopically
produced WNT7A and WNT7B stimulated luciferase activity
about 4- to 5-fold above the control vector, but GPR124 expres-
sion in BKO-124i cells potentiated signaling a further 3-fold. The
WNT2-positive control also stimulated luciferase activity in the
reporter cells, but in a GPR124-independent manner (Figure 2G).
These results suggest that GPR124 is involved inWNT7 signaling
that occurs after WNT7 binds to target cells.
Mature WNT7A and WNT7B share 82% amino acid identity
and WNT7B can compensate for loss of WNT7A in the devel-
oping CNS (Daneman et al., 2009; Stenman et al., 2008). How-
ever, homozygous disruption of Wnt7a alone results in limb
defects (Parr and McMahon, 1995), and homozygous missense
mutations inWNT7A in humans cause Fuhrmann syndrome and
Al-Awadi/Raas-Rothschild syndrome, which are also character-
ized by limb abnormalities (Woods et al., 2006). It is currently un-
clear if the limb defects caused by mutation in WNT7A are a
result of alterations in canonical and/or noncanonical signaling,
although indirect evidence has been provided for both pathways
(Adamska et al., 2004; Kengaku et al., 1998). Because GPR124
overexpression in BKO reporter cells provides a highly sensitive
readout for measuring WNT7A induced canonical b-catenin
signaling, we tested each of the previously reported WNT7Amu-(C) Coimmunoprecipitation (IP) studies revealed binding of HA-taggedDLG1 (DLG
acid deletion (GPR124-D4aa). IB, immunoblotting antibody.
(D) WNT7A-induced luciferase activity in BKO reporter cells in response to increa
constant amount of WNT7 (40 ng) was transfected into samples marked ‘‘+.’’
(E) Immunoblotting with anti-FLAG antibodies revealed similar levels of protein fo
receptor (GPR124-FL) and the corresponding four-amino-acid deletion (GPR124
(F) Immunofluorescence staining of nonpermeabilized cells with anti-FLAG an
GPR124-D4aa in transfected BKO cells. The nuclei (blue) were counterstained w
(G) Schematic diagram of full-length (FL) GPR2124 and the N-terminal deletion m
(H) Incorporation of an RGE motif in place of the RGD site did not alter GPR124’
(I) Western blotting revealed expression of the N-terminal GPR124 deletions. T
(asterisk) providing a convenient internal loading control.
(J) Immunofluorescence staining of permeabilized BKO cells with anti-myc ant
pattern for GPR124-myc (full-length GPR124 with a C-terminal myc tag) and eac
Scale bar, 10 mm.
(K) BKO reporter assays revealed a loss of b-catenin stimulation by all of the N-t
(L) BKO reporter assays revealed that the LRR domain of GPR125 is able to par
Data are mean ± SEM.
Ctants in our reporter assay. Western blotting revealed each of the
mutant proteins was expressed at a similar level following trans-
fection into BKO cells (Figure 3A). All six mutations resulted in
complete or nearly complete loss of GPR124-induced luciferase
activity (Figure 3B). These results support the possibility that
WNT7A-induced canonical b-catenin signaling is important for
limb morphogenesis.
GPR124’s Activity Is Regulated by Its Extracellular LRR
Domain and Its Intracellular PDZ Binding Motif
To better understand the role of GPR124, next we began a
search for interacting partners using a mass spectrometry
approach. For this, we immunoprecipitated GPR124 from
immortalized human cerebral microvascular endothelial cells
(hCMECs) engineered to express a doxycycline-inducible
FLAG-tagged GPR124 expression vector (hCMEC/GPR124i)
(Cullen et al., 2011). Immunoprecipitations from noninduced
hCMEC/GPR124i and parent hCMECs served as negative con-
trols. Mass spectrometry analysis identified Disks large homolog
1 (DLG1) as one of the most abundant interactors, with 43 pep-
tides in the doxycycline-treated hCMEC/GPR124 group versus
zero peptides in each of the control groups. DLG1 has previously
been shown to bind APC, an essential component of the b-cat-
enin destruction complex, and Yamamoto and coworkers previ-
ously identified GPR124 as an interacting partner for DLG1 using
a yeast two-hybrid approach that employed DLG1 as bait (Ya-
mamoto et al., 2004). In that study, the authors demonstrated
that the PDZ domain of DLG1 bound to the last four amino acids
of GPR124, ETTV, which represents a canonical PDZ-binding
motif. Using coimmunoprecipitation studies, we verified that
the last four amino acids of GPR124 were essential for binding
DLG1 (Figure 3C). To determine if this interaction could be
involved in GPR124-mediated coactivation of WNT7 signaling,
we compared the four-amino-acid deletion (GPR124-D4aa)
with the full-length receptor in dose-response studies and found
that it displayed a consistent reduction in activity compared to
full-length receptor (Figure 3D). GPR124 and GPR124-D4aa
were expressed at similar levels (Figure 3E), and both receptors
were located at the cell surface (Figure 3F), indicating that the
reduced potentiation was not caused by reduced expression
or trafficking to the cell surface. These results demonstrate-HA) to full-length FLAG-taggedGPR124 (GPR124-FL), but not the four-amino-
sing amounts of either GPR124-D4aa or the full-length vector (GPR124-FL). A
llowing transient transfection of cells with the full-length FLAG-tagged GPR124
-D4aa). b-actin was used as a loading control.
tibodies (green) revealed similar expression of GPR124-FL (full-length) and
ith DAPI. N.S., nonsignificant. Scale bar, 10 mm.
utants. SP, signal peptide; 7TM, seven-pass transmembrane domains.
s ability to activate WNT7A b-catenin signaling.
he anti-myc antibody also cross-reacted with a product present in all lanes
ibodies (green) 48 hr posttransfection revealed a similar membrane-staining
h of the N-terminal deletions. The nuclei (blue) were counterstained with DAPI.
erminal GPR124 deletions. *p = 0.0001
tially rescue luciferase activity in the DLRR mutant.
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that the PDZ binding motif is required for maximal potentiation of
WNT7-induced canonical b-catenin signaling (Figure 3D).
GPR124 also has several structural domains in its N-terminal
region that could be involved in the coactivation of WNT7
signaling, including a set of leucine-rich repeats (LRRs), a LRR
C-terminal (LRR-CT) domain, an immunoglobulin (IG) domain,
a hormone (Horm) domain containing an RGD (Arg-Gly-Asp)
motif, and a membrane proximal GPS domain (Figure 3G). Pro-
teolytic exposure of the cryptic RGD site in GPR124 has been
shown to mediate binding to integrin avb3, and it has been
postulated that this interaction regulates adhesion andmigration
during angiogenesis (Vallon et al., 2010, 2012). To determine
whether the RGD site was important for GPR124 mediated
potentiation of WNT7 signaling, we cotransfected BKO cells
withWNT7A and amutant GPR124 receptor containing an integ-
rin blocking D357E point mutation (RGD/ RGE) but found no
difference in coactivation compared to wild-type GPR124 (Fig-
ure 3H). Next, we generated a series of N-terminal deletions,
removing one additional domain with each construct (Figure 3G).
Western blot and immunofluorescence analysis demonstrated
that the full-length protein and each of the truncated proteins
were expressed at comparable levels (Figure 3I) with a similar
cell-surface staining (Figure 3J). However, when expressed in
BKO cells, each of the truncated proteins was nonfunctional,
indicating that the most N-terminal deletion, lacking only the
LRRs, was sufficient to completely block GPR124 mediated
potentiation of WNT7 signaling (Figure 3K). Swapping the LRR
in the extracellular domain of GPR124 with the LRR domain of
GPR125 resulted in a fusion protein, called GPR124/125LRR,
that largely rescued potentiation of WNT7 signaling (Figure 3L).
Because the full-length GPR125 receptor is unable to potentiate
signaling, there are likely other regions outside of the LRR
domain that are also required for potentiation but are missing
in GPR125. These results also suggest that conserved residues
within the LRR domains of GPR124 and GPR125 are important
for signaling potentiation.
Genetic Evidence for a Common GPR124/WNT7
Signaling Pathway In Vivo
To further assess the importance of GPR124 in regulating WNT7
activity in vivo, next we sought evidence for a genetic interaction
betweenGpr124 andWnt7. So far, no CNS angiogenesis defects
have been reported in heterozygousGpr124+/mice, suggesting
that one copy ofGpr124 is sufficient for normal development (An-
derson et al., 2011; Cullen et al., 2011; Kuhnert et al., 2010). Simi-
larly, mice with three out of four mutant Wnt7 alleles (Wnt7a/;
Wnt7b+/) display minimal, if any, defects in CNS development
(Daneman et al., 2009; Stenman et al., 2008). We reasoned that
if GPR124 and WNT7 function in the same pathway, then loss
of one Gpr124 allele could make mice more sensitive to reduc-
tions inWNT7 expression levels. To test this hypothesis, we eval-
uated the CNS vasculature in compound mutant E13.5 embryos
lacking one Gpr124 allele and three out of fourWnt7 alleles (i.e.,
genotype: Gpr124+/; Wnt7a/; Wnt7b+/). These studies re-
vealed a clear defect in vascular morphogenesis in the com-
pound mutants (Figure 4A). However, no CNS defects were
observed in theGpr124+/ orWnt7a/;Wnt7b+/ control groups
(Figure S4A), consistent with earlier reports (Cullen et al., 2011;128 Cell Reports 10, 123–130, January 13, 2015 ª2015 The AuthorsStenman et al., 2008). Although the defects were less severe
than those found in Gpr124 knockout or Wnt7a/Wnt7b double-
knockout mice, in the forebrain, abnormal glomeruloids were
consistently observed in the region of ganglionic eminence
(Figure 4A) (100% penetrance, n = 6). We also observed glomer-
uloids in the ventral region of the spinal cord of compound
heterozygotes (Figure 4B). Staining for the erythrocyte marker
TER119 (Ly76) revealed sporadic hemorrhaging from the glomer-
uloids (Figure S4B), although the extent of hemorrhage was
much less than in Gpr124 null and Wnt7a/Wnt7b null mice. Re-
sidual expression of both GPR124 and WNT7A from the remain-
ing wild-type allele presumably accounts for the less severe
defects compared to Gpr124 or Wnt7a/Wnt7b null mice.
The hemorrhaging observed in the compound mutant sug-
gested that barrier properties may also be compromised. To
assess this, we evaluated expression of glucose transporter-1
(Glut1), a widely used indicator of BBB integrity (Bauer et al.,
1995). Glut1 levels were low or absent in the glomeruloids of
the compound mutant mice (Figures 4A, 4B, S4A, and S4C).
Conversely, we found an increase in plasmalemma vesicle-asso-
ciated protein (PVLAP) (Figure S4C), a marker of stomatal and
fenestral diaphragms that is normally silenced with tightening
of the BBB and absent from mature CNS vasculature (Shue
et al., 2008). Taken together, these studies suggest that
GPR124 and WNT7 cooperate to regulate angiogenesis and
establishment of BBB properties in the developing CNS.
In these studies, we establish GPR124 as a WNT7-specific
coactivator of canonical b-catenin signaling. Zhou et al. also
recently demonstrated the importance of GPR124 in promoting
WNT7-induced b-catenin signaling using a 293-based luciferase
reporter (Zhou and Nathans, 2014). Similar to our study (see Fig-
ure S1), in 293 reporter cells, they observed a biphasic response
to increasing GPR124 levels that included an increase in WNT7-
induced b-catenin signaling followed by a partial decrease in
signaling at the highest levels of GPR124. Although the physio-
logical relevance of the partial decrease in signaling in 293 re-
porter cells is currently unclear, in BKO reporter cells, we only
observed a dose-dependent increase in WNT7-induced b-cate-
nin signaling with increasing levels of GPR124. Using BKO cells,
we also demonstrate that GPR124 enhanced the WNT7 induc-
tion of the endogenous b-catenin response genes Axin2 and
Apcdd1. The results we obtained using human GPR124 and
WNT7 were similar to those obtained with the murine counter-
parts, demonstrating that GPR124s role in potentiation of
WNT7 signaling has been conserved through evolution. While
Zhou et al. demonstrated a genetic interaction between
Gpr124 and either b-catenin or Norrin, we provide evidence for
a genetic interaction between Gpr124 andWnt7a/Wnt7b in vivo.
In our reporter assays, we consistently observed some induc-
tion (2- to 5-fold) of luciferase activity by WNT7 in Gpr124/
BKO reporter cells. Because GPR124 is not absolutely essential
for WNT7 signaling we propose that GPR124 functions as a co-
activator, modulating endogenous frizzled/LRP complexes and
heightening their sensitivity to WNT7A/WNT7B. We speculate
that ligand-specific coactivators may have evolved to help guide
cell-specific WNT responses in complex tissue environments
where multiple WNTs are competing for multiple frizzled recep-
tors. Although GPR124 is a specific coactivator for WNT7A
Figure 4. Genetic Interaction Studies
Reveal Cooperation among Gpr124,
Wnt7a, and Wnt7b In Vivo
(A) Isolectin (ISL) staining revealed unusual glo-
meruloid structures (arrowheads) in the ganglionic
eminence (GE) of Gpr124+/;Wnt7a/;Wnt7b+/
forebrains. Note the reduced level of Glut1 in the
glomeruloid structures. V, ventricle. Scale bar,
100 mm.
(B) Isolectin (ISL) staining revealed unusual glo-
meruloid structures (arrows) in the ventral (v) re-
gion of Gpr124+/; Wnt7a/; Wnt7b+/ spinal
cords. Scale bar, 100 mm.
See also Figure S4.and WNT7B, it seems likely that multiple frizzleds can mediate
these signals. First, all ten frizzleds were detected in BKO cells.
Second, none of the frizzled knockout mice have CNS angiogen-
esis defects in the forebrain and ventral spinal cord similar to
Gpr124/ or Wnt7a//Wnt7b/ mice (van Amerongen and
Berns, 2006).
Although GPR124 displays widespread expression in CNS
vasculature, angiogenesis defects in Gpr124/ mice were
only observed in the forebrain and ventral spinal cord. These lo-
cations correspond with the previously described localized
expression patterns of Wnt7a and Wnt7b (Daneman et al.,
2009; Stenman et al., 2008) and provide a likely explanation for
the anatomical specificity of the CNS defects observed in the
Grp124/ mice.
Through mutational analysis we identified several key regions
of WNT7 and GPR124 that are involved in potentiation of b-cat-
enin signaling. On the C terminus of GPR124, we show that the
last four amino acids are critical for maximal signaling potentia-
tion and that this region binds DLG1. We also demonstrate the
importance of the N-terminal LRR domain of GPR124 inCell Reports 10, 123–130WNT7-induced b-catenin signaling. Our
mutational analysis should help facilitate
future efforts to further unravel the mech-
anisms underlying GPR124-selective
potentiation of WNT7 signaling.
The adhesion GPCRs represent the
second largest family of GPCRs but are
currently the least understood. The well-
known druggability of GPCRs makes
GPR124 an interesting potential target
for regulating CNS-specific angiogenesis
or barriergenesis. The fact that GPR124 is
also upregulated in tumor vasculature
suggests that manipulation of GPR124
also holds promise for the development
of new antiangiogenic agents to block tu-
mor growth.
EXPERIMENTAL PROCEDURES
Animals
Mice were housed in a pathogen-free facility certi-
fied by the Association for Assessment andAccreditation of Laboratory Animal Care International, and the studies were
carried out in accordance with protocols approved by the NCI Animal Care
and Use Committee.
Statistical Analysis
A Mann-Whitney test was used to calculate p values for the b-galactosidase
staining, and a Student’s t test was used for all other comparisons. Differ-
ences between two groups are presented as the mean ± SEM. All tests
were two sided, and p values < 0.05 were considered statistically
significant.
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